Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women

Breast Cancer Research and Treatment(2020)10.1007/s10549-020-05643-0Source: DataRank Database

Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women is a research paper published in Breast Cancer Research and Treatment (2020). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.72)OA: hybridTopics (65)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Xingyi Guo ORCID,Wanqing Wen ORCID,Jiajun Shi ORCID,Jirong Long ORCID,Qiuyin Cai ORCID

Live enrichment

PubMed:32318955 PMC:PMC7188717 OpenAlex:https://openalex.org/W3016971033

National Institutes of Health

Grant: R01CA158473

National Institutes of Health

Grant: T32CA160056

NCI NIH HHS

Grant: UM1 CA182910

FWCI

2.72

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s10549-020-05643-0.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s10549-020-05643-0.pdf

publisherhttps://link.springer.com/article/10.1007/s10549-020-05643-0/fulltext.html

journalhttps://doi.org/10.1007/s10549-020-05643-0

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32318955

Fields of Study

BRCA gene mutations in cancerBreast Cancer Treatment StudiesGenetic factors in colorectal cancerAdultAgedBRCA1 ProteinBRCA2 ProteinBiomarkers, TumorBreast NeoplasmsCase-Control StudiesCheckpoint Kinase 2ChinaFanconi Anemia Complementation Group N ProteinFemaleFollow-Up StudiesGenetic Predisposition to DiseaseGenetic TestingGerm-Line MutationHumansMiddle AgedPrognosisErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, Progesterone

MeSH Terms

Fanconi Anemia Complementation Group N ProteinAdultAgedBreast NeoplasmsChinaFemaleFollow-Up StudiesGenetic TestingHumansMiddle AgedPrognosisReceptors, EstrogenReceptors, ProgesteroneBiomarkers, TumorCase-Control StudiesGerm-Line MutationReceptor, ErbB-2Erb-b2 Receptor Tyrosine KinasesBRCA1 ProteinGenetic Predisposition to DiseaseBRCA2 ProteinCheckpoint Kinase 2

Keywords

CHEK2PALB2Breast cancerGenetic predispositionCancerGeneticsExome sequencingPopulationGermline mutationGenetic testingBiologyMedicineOncologyMutationGeneBreast Cancer RiskChinese WomenClinical Genetic TestingHereditary Breast Cancer Syndromes

Sustainable Development Goals

SDG 0: Good health and well-being

Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women

FAIR Checklist

Authors (9)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)